ArticleVeterinary sciences2025
Five Amino Acid Substitutions in the S1 Unit of Infectious Bronchitis Virus Are Critical Determinants Enhancing Its Adaptation to Vero Cells.
Article in Veterinary sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The S1 subunit of the spike protein of avian infectious bronchitis virus (IBV) plays a crucial role in determining its host range and cell and tissue tropism. Following the continuous passage of IBV-EP3 through Vero cells over up to 65 generations, a total of 19 amino acid mutations accumulated in the S1 region of IBV-P65. To investigate the impact of these mutations on the adaptability of IBV to Vero cells, six recombinant viruses carrying either a subset or all of the identified mutations were constructed and obtained via a reverse genetics system. Analyses on the growth characteristics of these recombinant viruses and Western blot detection of the expression levels of their spike proteins indicated that the IBV mutant obtained by replacing the amino acid sequence from positions 179 to 323 in the S1 region of IBV-P65 with the corresponding segment from IBV-EP3 S1 significantly impaired viral growth and exhibited a lower replication efficiency in Vero cells, suggesting that five amino acid substitutions (T181I, I246T, F267C, T273I, Q296K) within this region could enhance the adaptation of IBV to Vero cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.